Evidence map›Paper›PMID 38815229›Full record

ArticleBlood advances2024

Determinants of cognitive dysfunction in adults with sickle cell-related stroke or suspected neurological morbidity.

Despina Messimeris, Hugo Bismuth, Corentin Provost, Clémentine Emaer, Nicolas Mélé, Robert Kitenge, Jean-Benoit Arlet, Laure Joseph, Brigitte Ranque, Pablo Bartolucci and 2 more

Abstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Despina MessimerisInstitute of Psychiatry and Neuroscience of Paris, INSERM U1266, Paris, France.ORCID 0009-0003-6113-1151
Hugo BismuthNeurology Department, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, Université Paris Cité, Paris, France.
Corentin ProvostInstitute of Psychiatry and Neuroscience of Paris, INSERM U1266, Paris, France.ORCID 0000-0002-0200-4027
Clémentine EmaerNeurology Department, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, Université Paris Cité, Paris, France.
Nicolas MéléNeurology Department, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, Université Paris Cité, Paris, France.ORCID 0000-0001-5390-401X
Robert KitengeCentre de formation et d'appui sanitaire, Centre hospitalier Monkole, Kinshasa, Democratic Republic of the Congo.ORCID 0000-0002-5987-7742
Jean-Benoit ArletInternal Medicine Department, French National Sickle Cell Referral Center, Hôpital Européen Georges Pompidou, Assistance-Publique Hôpitaux de Paris, Université Paris Cité, Paris, France.
Laure JosephFrance Centre de référence des syndromes drépanocytaires majeurs, service de biothérapie, Centre d'investigation clinique, Hôpital Universitaire Necker-Enfants Malades, Université Paris Cité, Paris, France.
Brigitte RanqueInternal Medicine Department, French National Sickle Cell Referral Center, Hôpital Européen Georges Pompidou, Assistance-Publique Hôpitaux de Paris, Université Paris Cité, Paris, France.ORCID 0000-0001-8549-2275
Pablo BartolucciReferral Center for Sickle Cell Disease and Red Blood Cell Disorders, UMGGR, Paris Est Créteil University, IMRB, INSERM U955, Créteil, France.
Pauline NarmeLaboratoire Mémoire Cerveau et Cognition, UR 7536, Institut de Psychologie, Université Paris Cité, Paris, France.
David CalvetInstitute of Psychiatry and Neuroscience of Paris, INSERM U1266, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractThe prognosis of sickle cell disease (SCD) in adults is determined primarily by damage to targeted organs such as the brain. Cognitive dysfunction in SCD is a common chronic neurological manifestation, but studies remain mostly descriptive in adults. The objective of this study was to better characterize the cognitive profile and the association between cognitive dysfunction and brain lesions. We included adult patients with SCD referred for a neurological assessment. An adapted battery of neuropsychological tests was used to assess cognitive deficits. Brain or arterial abnormalities were assessed using brain magnetic resonance imaging/magnetic resonance angiography and a cervical and transcranial Doppler ultrasound. The cognitive profile of 96 patients was characterized by deficits in processing speed (58%), short-term memory (34%), and working memory (24%). Brain infarcts were found in 56% of patients and intracranial vasculopathy in 49%. Twenty percent of patients had no brain abnormalities. Processing speed dysfunction was associated with territorial infarcts (odds ratio [OR], 3.1; P = .03) and education outside of France (OR, 4.7; P = .02). Short-term memory dysfunction was associated with territorial infarcts (OR, 3.4; P = .01) and a low educational level (OR, 8.2; P = .01). Working memory dysfunction was associated with a low educational level (OR, 4.3; P = .05) and vasculopathy (OR, 3.7; P = .03). Cognitive dysfunction appears to be a hallmark sign of SCD, particularly for adults with sickle cell-related stroke or suspected neurological morbidity. Assessment of such dysfunction could be used in longitudinal follow-up and clinical trials.

Indexed as

Anemia, Sickle CellCognitive DysfunctionStrokeAdultFemaleHumansMaleMiddle AgedNeuropsychological TestsYoung Adult

Identifiers

PMID38815229
PMCPMC11339041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.